Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

18.41
Delayed Data
As of Aug 28
 +0.37 / +2.05%
Today’s Change
7.51
Today|||52-Week Range
25.25
+90.78%
Year-to-Date

Today’s Trading

Previous close18.04
Today’s open17.86
Day’s range17.84 - 18.55
Volume1,285,045
Average volume (3 months)1,553,136
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+20.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book55.97

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+1.38+2.53%
RDUSRadius Health Inc+0.70+1.11%
MCRBSeres Therapeutics I...+0.53+1.31%
OPHTOphthotech Corp+0.05+0.11%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

Partner Offers